Connection

Edouard Tuaillon to Biomarkers, Tumor

Back to Details
This is a "connection" page, showing publications Edouard Tuaillon has written about Biomarkers, Tumor.
Edouard Tuaillon
Connection Strength
0.022
Biomarkers, Tumor
  1. miR-125b and miR-532-3p predict the efficiency of rituximab-mediated lymphodepletion in chronic lymphocytic leukemia patients. A French Innovative Leukemia Organization study. Haematologica. 2017 04; 102(4):746-754.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.